| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |